Unveiling Pretomanid profiling using LC–MS/MS: integrating in-silico toxicity assessment and molecular docking analysis
Authors:
- 5 December 2024
- journal article
- research article
- Published by Springer Nature in Chemical Papers
- Vol. 79 (2) , 817-837
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Molecular docking studies of some benzoxazole and benzothiazole derivatives as VEGFR-2 target inhibitors: In silico design, MD simulation, pharmacokinetics and DFT studiesIntelligent Pharmacy, 2024
- Trace detection of perfluorooctanoic acid and perfluorooctane sulfonate in surface sediments using a liquid chromatograph coupled to an electrospray ionization single quadrupole mass spectrometer (LC-ESI–Q-MS)Microchemical Journal, 2024
- Development and validation of stability‐indicating ‐HPLC method for the determination of related substances in novel nitroimidazole antituberculosis drug pretomanid: Robustness study by Design‐Expert and application to stability studiesBiomedical Chromatography, 2022
- Pretomanid for tuberculosis: a systematic reviewClinical Microbiology and Infection, 2022
- A validated liquid chromatography tandem mass spectrometry assay for the analysis of pretomanid in plasma samples from pulmonary tuberculosis patientsJournal of Pharmaceutical and Biomedical Analysis, 2021
- Molegro Virtual Docker for Docking2019
- Simultaneous HPLC assay for pretomanid (PA-824), moxifloxacin and pyrazinamide in an inhaler formulation for drug-resistant tuberculosisJournal of Pharmaceutical and Biomedical Analysis, 2017
- 1,1‐Dihydroperoxides2014
- Degradation studies of pentoxifylline: Isolation and characterization of a novel gem-dihydroperoxide derivative as major oxidative degradation productJournal of Pharmaceutical and Biomedical Analysis, 2010
- Hydrolysis in Drug and Prodrug Metabolism2003